RANK

Rosalind “Roz” Brewer, who stepped in as CEO in March 2021, had plenty to celebrate after her first year in the job. Walgreens Boots Alliance’s profits increased by a whopping 457.5% over the prior year, to $2.5 billion, as the drugstore chain became a major point of sale for at-home rapid COVID tests and COVID vaccines. In October 2021, Walgreens intensified its involvement in the primary care business, investing $5.2 billion to acquire a majority stake in VillageMD. With pharmacists experiencing increased burnout, the company has begun to embrace A.I.; it is on track to open 22 robot-powered prescription-refill hubs. Like other major drugstore chains, the company faces ongoing litigation alleging that its pharmacies helped worsen the opioid crisis; Walgreens’ attorneys have said the company’s pharmacists acted in good faith in filling opioid prescriptions.

Nancy Stone—Chicago Tribune/Tribune News Service/Getty Images

Company Information

As of 6/5/23

Country

U.S.

Headquarters

Deerfield, Ill.

Industry

Food and Drug Stores

CEO

Roz Brewer

Website

www.walgreensbootsalliance.com

Company Type

Public

Ticker

WBA

Revenues ($M)

$132,703

Profits ($M)

$4,337

Market Value ($M)

$29,836

Employees

262,500

Figures are for fiscal year ended Aug. 31, 2022. Market value as of March 31, 2023.

Key Financials (Last Fiscal Year)
As of 8/3/2022

($ Millions)

% change

Revenues ($M)

$148,579

6.5%

Profits ($M)

$2,542

457.5%

Assets ($M)

$81,285

Total Stockholder Equity ($M)

$23,419

Profit Ratios
As of 8/3/2022

Profit as % of Revenues

1.7%

Profits as % of Assets

3.1%

Profits as % of Stockholder Equity

10.9%

Walgreens Boots Alliance Rank History

Historical Data

Year	Revenues ($M)	Profits ($M)	Assets ($M)	Total Stockholder Equity ($M)
2021	$139,5372%	$456-88.5%	$87,174	$20,637
2020	$136,8664.1%	$3,982-20.7%	$67,598	$23,512
2019	$131,53711.3%	$5,02423.2%	$68,124	$26,007
2018	$118,2140.7%	$4,078-2.3%	$66,009	$27,466
2017	$117,35113.4%	$4,173-1.1%	$72,688	$29,880